Racial Differences in the Overall Survival of Hairy Cell Leukemia in the United States: A Population-Based Analysis of the Surveillance, Epidemiology, and End Results Database

Clinical Lymphoma, Myeloma and Leukemia

Volumn 15, Issue 8, 2015, Pages 484-488

  Giri, Smith ^a   Shrestha, Rajesh ^b   Pathak, Ranjan ^c   Bhatt, Vijaya Raj ^d  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c Reading Health System   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

African American; Caucasian; Indolent B cell lymphoproliferative disorder; Marital status; Racial disparity

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ALASKA NATIVE; AMERICAN INDIAN; ARTICLE; ASIAN; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER SURVIVAL; CAUCASIAN; DATA BASE; FEMALE; HAIRY CELL LEUKEMIA; HEALTH SURVEY; HISPANIC; HUMAN; LIFE TABLE METHOD; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIDDLE AGED; OVERALL SURVIVAL; PACIFIC ISLANDER; POPULATION RESEARCH; RACE DIFFERENCE; UNITED STATES; ANCESTRY GROUP; LEUKEMIA, HAIRY CELL; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 84937813457     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2015.03.001     Document Type: Article

References (41)

1. B.A. Bouroncle Leukemic reticuloendotheliosis (hairy cell leukemia) Blood 53 1979 412 436
2. L. Bernstein, P. Newton, and R.K. Ross Epidemiology of hairy cell leukemia in Los Angeles County Cancer Res 50 1990 3605 3609
3. H.M. Golomb, D. Catovsky, and D.W. Golde Hairy cell leukemia: a clinical review based on 71 cases Ann Intern Med 89 1978 677 683
4. S.H. Swerdlow, F. Berger, P.I. Isaacson, and et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2001 IARC Press Lyon
5. M.R. Grever How I treat hairy cell leukemia Blood 115 2010 21 28
6. M.S. Tallman, L.C. Peterson, D. Hakimian, S. Gillis, and A. Polliack Treatment of hairy-cell leukemia: current views Semin Hematol 36 1999 155 163
7. M. Federico, A. Frassoldati, T. Lamparelli, and et al. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL Ann Oncol 5 1994 725 731
8. L.D. Piro, D.J. Ellison, and A. Saven The Scripps Clinic experience with 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia Leuk Lymphoma 14 suppl 1 1994 121 125
9. P. Chadha, A.W. Rademaker, P. Mendiratta, and et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience Blood 106 2005 241 246
10. M. Grever, K. Kopecky, M.K. Foucar, and et al. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study J Clin Oncol 13 1995 974 982
11. I.W. Flinn, K.J. Kopecky, M.K. Foucar, and et al. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin Blood 96 2000 2981 2986
12. G.R. Goodman, C. Burian, J.A. Koziol, and A. Saven Extended follow-up of patients with hairy cell leukemia after treatment with cladribine J Clin Oncol 21 2003 891 896
13. C.E. Dearden, E. Matutes, B.L. Hilditch, G.J. Swansbury, and D. Catovsky Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine Br J Haematol 106 1999 515 519
14. M. Else, R. Ruchlemer, N. Osuji, and et al. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years Cancer 104 2005 2442 2448
15. L. Falchi, M.J. Keating, X. Wang, and et al. Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemia: joint experience of the MD Anderson Cancer Center and Duke University Medical Center Cancer 119 2013 3177 3185
16. R. Chandran, S.K. Gardiner, S.D. Smith, and S.E. Spurgeon Improved survival in hairy cell leukaemia over three decades: a SEER database analysis of prognostic factors Br J Haematol 163 2013 407 409
17. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Overview of the SEER Program. Available at: http://seer.cancer.gov/about/overview.html. Accessed November 12, 2014.
18. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
19. A. Ghafoor, A. Jemal, V. Cokkinides, and et al. Cancer statistics for African Americans CA Cancer J Clin 52 2002 326 341
20. P.J. Shenoy, N. Malik, R. Sinha, and et al. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States Clin Lymphoma Myeloma Leuk 11 2011 498 506
21. A.M. Evens, M. Antillon, B. Aschebrook-Kilfoy, and B.C. Chiu Racial disparities in Hodgkin lymphoma: a comprehensive population-based analysis Ann Oncol 23 2012 2128 2137
22. C.R. Flowers, S.A. Fedewa, A.Y. Chen, and et al. Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States Cancer Epidemiol Biomarkers Prev 21 2012 1520 1530
23. W.B. Goggins, and F.F. Lo Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the SEER database 1988-2008 Cancer Causes Control 23 2012 737 743
24. T.H. Keegan, L.M. Moy, J.M. Foran, and et al. Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study Leuk Lymphoma 54 2013 743 751
25. M.I. Patel, Y. Ma, B.S. Mitchell, and K.F. Rhoads Understanding disparities in leukemia: a national study Cancer Causes Control 23 2012 1831 1837
26. C.C. Coombs, L. Falchi, J.B. Weinberg, A. Ferrajoli, and M.C. Lanasa Chronic lymphocytic leukemia in African Americans Leuk Lymphoma 53 2012 2326 2329
27. V.H. Murthy, H.M. Krumholz, and C.P. Gross Participation in cancer clinical trials: race-, sex-, and age-based disparities JAMA 291 2004 2720 2726
28. E. Ward, A. Jemal, V. Cokkinides, and et al. Cancer disparities by race/ethnicity and socioeconomic status Cancer J Clin 54 2004 78 93
29. S.M. Davies Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet? Hematology Am Soc Hematol Educ Program 2006 111 117
30. F. Forconi, E. Sozzi, E. Cencini, and et al. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior Blood 114 2009 4696 4702
31. E. Arons, J. Sunshine, T. Suntum, and R.J. Kreitman Somatic hypermutation and VH gene usage in hairy cell leukaemia Br J Haematol 133 2006 504 512
32. M.A. Hoffman, D. Janson, E. Rose, and K.R. Rai Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up J Clin Oncol 15 1997 1138 1142
33. L. Xi, E. Arons, W. Navarro, and et al. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation Blood 119 2012 3330 3332
34. E.A. Konig, W.C. Kusser, C. Day, and et al. p53 mutations in hairy cell leukemia Leukemia 14 2000 706 711
35. X. Wang, R. Spielberger, and Q. Huang Hairy cell leukemia variant, a new entity of the WHO 2008 J Clin Oncol 29 2011 e864 e866
36. M. Hisada, B.E. Chen, E.S. Jaffe, and L.B. Travis Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study J Natl Cancer Inst 99 2007 215 222
37. O. Paltiel, B. Adler, M. Barchana, and E.J. Dann A population-based study of hairy cell leukemia in Israel Eur J Haematol 77 2006 372 377
38. A.A. Aizer, M.H. Chen, E.P. McCarthy, and et al. Marital status and survival in patients with cancer J Clin Oncol 31 2013 3869 3876
39. T. Robak Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment Cancer Treat Rev 37 2011 3 10
40. A. Traverse-Glehen, L. Baseggio, E. Callet-Bauchu, and et al. Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity? Br J Haematol 150 2010 113 116
41. T. Robak Current treatment options in hairy cell leukemia and hairy cell leukemia variant Cancer Treat Rev 32 2006 365 376